XRTX Stock Price History and Quote Analysis Insights for Investors
XORTX Therapeutics Inc.
Stock Price Today
XORTX Therapeutics Inc. (XRTX) stock surged +1.91%, trading at $1.18 on NASDAQ, up from the previous close of $1.16. The stock opened at $1.19, fluctuating between $1.18 and $1.19 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is based in Vancouver, Canada.
Company Information
| Employees | 2 |
| Beta | -0.21 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
XORTX Therapeutics Inc. (NASDAQ: XRTX) stock price is $1.18 in the last trading session. During the trading session, XRTX stock reached the peak price of $1.19 while $1.18 was the lowest point it dropped to. The percentage change in XRTX stock occurred in the recent session was 1.91% while the dollar amount for the price change in XRTX stock was $0.02.
The NASDAQ listed XRTX is part of Biotechnology industry that operates in the broader Healthcare sector. XORTX Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Stephen Haworth M.D., MRCP
Chief Medical Officer
Nick Rigopoulos
Director of Communications
Dr. David Sans M.B.A., Ph.D.
Director of Corporation Devel.
Dr. Stacy Evans M.B.A., M.D.
Chief Bus. Officer
Mr. Amar Keshri C.A., CPA
Chief Financial Officer
Dr. David MacDonald Ph.D.
Consultant of Clinical Operations
Dr. Allen Warren Davidoff Ph.D.
Founder, Chief Executive Officer, Pres & Director
Ms. Charlotte May
Corporation Sec.
XRTX's closing price is 8.45% higher than its 52-week low of $1.09 where as its distance from 52-week high of $7.00 is -83.11%.
Number of XRTX employees currently stands at 2.
Official Website of XRTX is: https://www.xortx.com
XRTX could be contacted at phone 0 and can also be accessed through its website. XRTX operates from 421 – 7th Avenue SW, Vancouver, BC T2P 4K9, Canada.
XRTX stock volume for the day was 6.54K shares. The average number of XRTX shares traded daily for last 3 months was 58.9K.
The market value of XRTX currently stands at $4.56M with its latest stock price at $1.18 and 3.86M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com